However, real-world data shows conflicting persistence trends, with one study revealing that 63% of patients persist for at least one year, while another shows that one-third of people stopped taking their GLP-1 in the first month, and less than half stayed on for more than 12 weeks
Aftercare Programs After you have completed your ReStart shots, you can immediately go back to your routines
Short Answer: The standard rule is that the employee will have a proportional contribution limit based on the months of HSA eligibility, but in certain circumstances, the last-month rule will allow the employee to contribute to the full statutory limit
Womans World wants to hear YOUR experiences with tirzepatide, semaglutide, and your experiences with prescription weight loss or telehealth in general
Efficacy Outcomes: What Clinical Trials Show Semaglutide clinical trials reported average weight loss of 1222% over 68 weeks depending on dose, with significant cardiovascular benefits demonstrated in the SUSTAIN-6 trial
Some patients plateau at 1.0 mg and achieve their goals without needing higher doses, while others benefit from reaching 2.0 mg or combining semaglutide with complementary compounds
